Umeukeje, Ebele M.
Merighi, Joseph R.
Browne, Teri
Wild, Marcus
Alsmaan, Hafez
Umanath, Kausik
Lewis, Julia B.
Wallston, Kenneth A.
Cavanaugh, Kerri L. http://orcid.org/0000-0002-4031-1714
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (F32DK102366, T32DK007569, K23DK080952, DK103935-01A1)
National Institutes of Health (UL1 TR000445-06)
Article History
Received: 27 October 2015
Accepted: 19 April 2016
First Online: 11 May 2016
Change Date: 8 January 2019
Change Type: Correction
Change Date: 8 January 2019
Change Type: Correction
Change Details: In the original publication of the article, the majority of changes stem from misclassification of “medium adherence” when using the Morisky Medication Adherence Scale (MMAS-8) and not using the correct scoring algorithm for one of the responses when calculating MMAS-8 total scores.
Change Details: In the original publication of the article, the majority of changes stem from misclassification of ���medium adherence��� when using the Morisky Medication Adherence Scale (MMAS-8) and not using the correct scoring algorithm for one of the responses when calculating MMAS-8 total scores.
Compliance with ethical standards
:
: Ebele M. Umeukeje, Joseph R. Merighi, Teri Browne, Marcus Wild, Hafez Alsmaan, Kausik Umanath, Julia B. Lewis, Kenneth A. Wallston and Kerri L. Cavanaugh declare that they have no conflict of interest.
: All procedures used in this study conform to the ethical standards of the institutional review board of all the three sites. The procedures followed were also in accordance with the Helsinki Declaration of 1975 (revised in 2000). Written informed consent was obtained from all the subjects prior to their participation in this study.